Interactive Session:
5. Stewardship: Best Drivers of Change Debate
Wednesday, October 3, 2018: 1:30 PM-3:15 PM
Room: N 24

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the controversy surrounding the inclusion of the "end of life population" in antimicrobial stewardship programs
  • debate the best outcome measures for antimicrobial stewardship programs: clinical outcomes vs. antibiotic use data
  • discuss the advantages and disadvantages of including antifungals in an antimicrobial stewardship program

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital administrators, Hospital epidemiologists, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Pharmacists, Public health practitioners, Researchers

Tracks: Trainee, Pediatric ID, Epidemiology and Infection Control, Adult ID


Interactive Moderators:  Kristina Bryant, MD, University of Louisville and Debra Goff, PharmD, Ohio State University

Presentations:
1:30 PM
11
1:47 PM
12
Best Outcome Measures: Usage Data
Conan Macdougall, PharmD, MAS, BCPS

2:04 PM
13
2:38 PM
15
End-of-Life Patient Population: Pro
Manisha Juthani-Mehta, MD, FIDSA, FSHEA

2:55 PM
16

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.75 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-183-L04-P

Disclosures:

K. Bryant, Pfizer: Investigator , Research support . PIDS: Board Member , No financial support . SHEA: Board Member , No financial support . MedStudy: Faculty for CME product , Honorarium .

D. Goff, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.